Belluscura Share Discussion Threads

[buywell2] 21/4/2022 06:21

POST REMOVED

[maytrees] 13/4/2022 10:27

Good morning
My further small buy, shows as the first sell of the day.

[buywell2] 12/4/2022 22:50

POST REMOVED

[buywell2] 12/4/2022 22:45

POST REMOVED

[buywell2] 11/4/2022 21:36

POST REMOVED

[buywell2] 08/4/2022 22:39

POST REMOVED

[buywell2] 08/4/2022 22:13

POST REMOVED

[maytrees] 08/4/2022 10:30

Presumably TEK share price will show some gain too if this BELL share price gain continues.

[maytrees] 08/4/2022 09:39

Good morning

Decent share price gain so far.

[maytrees] 07/4/2022 07:49

Meanwhile, shorters should stick to betting shops imho or at least not 'borrow' others shares without express prior consent.

[maytrees] 07/4/2022 07:36

Good morning
A small tick up in the share price so far is welcome but more to come imho.

[brummy_git] 07/4/2022 06:30

More great news from medical devices firm Belluscura

Find out all the news & commentary here.

hxxps://www.linkedin.com/posts/paul-hill-a5994116_bell-bell-activity-6917719666991730688-6jUA?utm_source=linkedin_share&utm_medium=member_desktop_web

[buywell2] 07/4/2022 06:18

POST REMOVED

[buywell2] 06/4/2022 06:41

POST REMOVED

[maytrees] 05/4/2022 07:22

Good morning
Clever appointment of new head of commercial strategy imho. He has had experience in portable 02

[buywell2] 05/4/2022 06:33

POST REMOVED

[buywell2] 02/4/2022 23:42

POST REMOVED

[brummy_git] 02/4/2022 05:32

Justin Waite & I of Vox markets talked positively about BELL y'day here (starts 24:50)

www.voxmarkets.co.uk/articles/stocks-to-follow-on-vox-markets-01-04-22-e84b46e/

www.youtube.com/watch?v=hnrHU3wl1l8&t=386s

[buywell3] 01/4/2022 07:50

MM's are going to have their work cut out from here on in with TEK and BELL now double teaming

When Lucyd also gets IPO'd things are set to get worse guys

Then Salarius and Microsalt come next

Mr Ashley James passed his apprentice buywell3 ---- all his papers as well as of all of his training and thoughts whilst he still could

buywell3 is thus very well prepared

[buywell2] 31/3/2022 21:20

POST REMOVED

[buywell3] 30/3/2022 20:46

That is true Dr Biotech

The world does now appear to be in the process of splitting into two main trading factions as the Americas get closer to EMEA --- so one would expect the USA based manufacturing locations that Belluscura will use in the USA will also service EMEA

hxxps://www.mapsofworld.com/answers/world/what-is-apac-and-emea/#

However a good business strategy would be to find a way to be able to service the requirements of both factions by the placement of manufacturing facilities with an established, respected and technically able partner/s that was already helping the government of the countries selected.


APAC countries are those located within the APAC geographical region.
The APAC region is loosely defined but generally considered to encompass the area in and around the western Pacific Ocean.

Russia does indeed look like having much closer trading ties with China --- as the above post points out

So add oxygen concentrator sales to Russia going forwards when the dust settles as it will --- with the Chinese manufacturer supplying Russia with them

A HUGE market opportunity then --- and as the RNS stated
" the agreement will more than double our manufacturing capacity and will provide access to the significantly larger Asian market - in China alone there are five times the COPD cases than in the US"

In the following link:

The areas of very high COPD prevalence, are represented by intense red shadows.
In the Russian regions of the East European Plain and the Central Siberian Plateau bordering Ukraine, Kazakhstan and Mongolia, the mean prevalence was 21.8%



There could be as many COPD sufferers in Russia as there are in the USA due to misdiagnosis

COPD is an important health care problem due to its high prevalence and impact in terms of morbidity and mortality.
A recent study conducted in 12 regions of the Russian Federation observed a prevalence of COPD of 15.3% related to the high rates of smoking in the Russian population.
In addition, other studies have demonstrated the magnitude of the misdiagnosis of COPD in Russia and the particular characteristics of the COPD patients in this country.
In a study of more than 1,500 Russian COPD patients, 53% had a forced expiratory volume in one second (% predicted) below 50% and up to 51% were frequent exacerbators.
In a large survey in middle and Eastern Europe, the Russian patients with COPD were among those with the highest prevalence of frequent exacerbators.
The high prevalence of the disease, the high rates of misdiagnosis, and the level of severity of the patients attended in Russian centers indicate the need for the development and implementation of a national clinical practice guideline (CPG) to improve the management of this disease.

see




dyor

[buywell4] 30/3/2022 07:17

Buywell does not like things made in China.


There is now a very real chance that Ru-sia will become a number one trading partner with Chi-nah

A major supplier of many commodities that the ROW may well shun

This of course comes with risk for both

Personally buywell now likes UK green investments only or those with a UK presence and located or also operating in the U-S of A or perhaps doing business with Japan or Australia or Canada

[buywell2] 30/3/2022 07:10

POST REMOVED

[buywell2] 30/3/2022 06:21

POST REMOVED

[buywell2] 21/3/2022 15:35

POST REMOVED